Combination immunotherapy in Japanese patients with advanced renal cell carcinoma: bridging gaps between clinical trials, real-world evidence, and the potential value of adverse events-a narrative review.

Saved in:
Bibliographic Details
Title: Combination immunotherapy in Japanese patients with advanced renal cell carcinoma: bridging gaps between clinical trials, real-world evidence, and the potential value of adverse events-a narrative review.
Authors: Iinuma K; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan., Tomioka M; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan., Taniguchi T; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan., Kawase K; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan., Tobisawa Y; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan., Nakane K; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan., Koie T; Department of Urology, Graduate School of Medicine, Gifu University, Yanagido, Gifu, Japan.
Source: Translational cancer research [Transl Cancer Res] 2025 Nov 30; Vol. 14 (11), pp. 8142-8153. Date of Electronic Publication: 2025 Nov 24.
Publication Type: Journal Article; Review
Journal Info: Publisher: Pioneer Bioscience Publishing Company Country of Publication: China NLM ID: 101585958 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2219-6803 (Electronic) Linking ISSN: 2218676X NLM ISO Abbreviation: Transl Cancer Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2219-6803
DOI:10.21037/tcr-2025-1859